Allakos Announces First Patient Dosed in Phase 1 Trial of Ak006 in Chronic Spontaneous Urticaria
Allakos宣佈在慢性自發性蕁麻疹的Ak006的1期試驗中首次給藥患者
Allakos Announces First Patient Dosed in Phase 1 Trial of Ak006 in Chronic Spontaneous Urticaria
Allakos宣佈在慢性自發性蕁麻疹的Ak006的1期試驗中首次給藥患者
譯文內容由第三人軟體翻譯。